Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Want to stay strong as you age? Doctor lists 5 supplements that may help
- 'Exponential' Ebola spread in DR Congo: UN urges immediate action
- Mpox Outbreak In Guinea-Bissau: 16 children under 4 among suspected cases, says study
- Think your heart is healthy? Doctor reveals 5 habits you should quit now
- Flying could be riskier than you think: Study shows pilots, flight attendants face highest radiation-linked cancer deaths
-1786284396.jpg "Image of the day: August 9, 2026")
